These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15928581)

  • 1. Ion channels in T cells: from molecular pharmacology to therapy.
    Krasznai Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):127-35. PubMed ID: 15928581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channels as therapeutic targets for autoimmune disorders.
    Wulff H; Beeton C; Chandy KG
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion channels and lymphocyte activation.
    Panyi G; Varga Z; Gáspár R
    Immunol Lett; 2004 Mar; 92(1-2):55-66. PubMed ID: 15081528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K+ channels and T-cell synapses: the molecular background for efficient immunomodulation is shaping up.
    Matkó J
    Trends Pharmacol Sci; 2003 Aug; 24(8):385-9. PubMed ID: 12915045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
    Koo GC; Blake JT; Shah K; Staruch MJ; Dumont F; Wunderler D; Sanchez M; McManus OB; Sirotina-Meisher A; Fischer P; Boltz RC; Goetz MA; Baker R; Bao J; Kayser F; Rupprecht KM; Parsons WH; Tong XC; Ita IE; Pivnichny J; Vincent S; Cunningham P; Hora D; Feeney W; Kaczorowski G
    Cell Immunol; 1999 Nov; 197(2):99-107. PubMed ID: 10607427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ion channels on T lymphocyte].
    Xiao L; Fu HY; Song DM; Fan SG
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):105-10. PubMed ID: 12889140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
    Varga Z; Hajdu P; Panyi G
    Immunol Lett; 2010 May; 130(1-2):19-25. PubMed ID: 20026117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
    Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
    Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
    Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
    Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitochondrial ion channels].
    Skalska J; Debska-Vielhaber G; Głab M; Kulawiak B; Malińska D; Koszela-Piotrowska I; Bednarczyk P; Dołowy K; Szewczyk A
    Postepy Biochem; 2006; 52(2):137-44. PubMed ID: 17078503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons.
    Shoudai K; Nonaka K; Maeda M; Wang ZM; Jeong HJ; Higashi H; Murayama N; Akaike N
    Brain Res; 2007 Jul; 1157():11-22. PubMed ID: 17555723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical and pharmacological aspects of K+ channels in T lymphocytes.
    Panyi G
    Eur Biophys J; 2005 Aug; 34(6):515-29. PubMed ID: 16184309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Ca(v) channels and AHNAK1 in T cells: the beauty and the beast.
    Matza D; Flavell RA
    Immunol Rev; 2009 Sep; 231(1):257-64. PubMed ID: 19754902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of store-operated Ca2+ entry channels and K+ channels by caffeic acid phenethylester in T lymphocytes.
    Nam JH; Shin DH; Zheng H; Kang JS; Kim WK; Kim SJ
    Eur J Pharmacol; 2009 Jun; 612(1-3):153-60. PubMed ID: 19371740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
    Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
    Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
    Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
    Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
    J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.
    Panyi G; Possani LD; Rodríguez de la Vega RC; Gáspár R; Varga Z
    Curr Pharm Des; 2006; 12(18):2199-220. PubMed ID: 16787250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.